Amylon Therapeutics announces seed investment round

Amylon Therapeutics announces seed investment round, focus on CNS disorders   Key updates Amylon Therapeutics B.V. is a spin-off company from ProQR Therapeutics N.V., a NASDAQ listed biopharmaceutical company based in Leiden, the Netherlands. Amylon announces the...